Follow Flash Finance FollowTelegram
53tech score
/ 100

Valiant Laboratories Limited (VALIANTLAB) — Technical Setup

₹125.84 -1.99%   Uptrend Normal Volatility Neutral

As of 2026-11-02 close Sector: Pharma Pharmaceuticals - Indian - Bulk Drugs & Formln All technical setups →

Summary

Valiant Laboratories Limited is in a uptrend on the daily chart, with the weekly trend bullish and the monthly trend bullish. RSI(14) is 52.3, MACD is below its signal line, ADX reads 18 (weak trend). The stock trades 59.5% above its 200-day average and 11.0% below its 52-week high. Volume in the latest session was 1.2× its 20-day average. Over three months it has outperformed the Nifty 50 by 111.0 percentage points. Nearest support is ₹112.12 and resistance ₹130.00. Its technical score is 53/100 (neutral).

Trend (daily)
Bullish
Trend (weekly)
Bullish
Trend (monthly)
Bullish
RSI (14)
52.31
MACD
Bearish
ADX (14)
18.07
Volume vs 20d avg
1.17×
Support
₹112.12 (−10.9%)
Resistance
₹130.00 (+3.3%)
RS vs Nifty (3M)
+111.04%
RS rating
97.00

🧮 How the 53/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend15/20
  • Close above 20-day EMA (-0.09)0/3
  • 20-day EMA above 50-day EMA3/3
  • 50-day EMA above 200-day EMA3/3
  • Close above 200-day SMA (59.55)3/3
  • SuperTrend (10,3) pointing up3/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (18.07)1/3
  • Weekly trend up (above a rising 30-week average)2/2
Momentum12/20
  • RSI(14) in the bullish zone (55-70 best) (52.31)4/6
  • MACD line above its signal line0/4
  • MACD line above zero (2.86)3/3
  • 12-day rate of change positive (2.78)3/3
  • Stochastic %K above %D0/2
  • Outperforming the Nifty 50 over 3 months (111.04)2/2
Volume15/20
  • On-balance volume rising over 20 sessions5/5
  • Chaikin Money Flow (20) positive (0.19)5/5
  • More volume on up days than down days (20 sessions) (1.20)5/5
  • Close above 20-day VWAP (-1.53)0/5
Volatility7/20
  • Daily range (ATR%) contained — ≤2.5% scores full (4.30)2/6
  • Price in the upper half of its Bollinger Bands (0.48)2/5
  • Shallow drawdown from the 52-week high (-10.99)3/5
  • Volatility contracting (20-day volatility below its 6-month median) (56.80)0/4
Support / Resistance4/20
  • Room to the next resistance (≥8% scores full) (3.31)1/5
  • Support close below (a tight, definable stop) (10.90)1/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-10.99)2/5

🧭 Regime: Uptrend

Normal Volatility — Bollinger width is in the 45th percentile of the last six months.

Suits: Trend-following, selectively. The trend is up but not forceful — favour entries near support and keep stops below the 50-day EMA.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the 20/50 EMA Crossover rules for VALIANTLAB — 20-day ema crosses above the 50-day ema.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly▲ Bullish50.478.70
Weekly▲ Bullish68.912.62
Daily▲ Bullish52.31-1.09

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bullish, weekly ADX 37.47.

📶 Volume & VWAP

Relative volume
1.17×
5d / 20d volume
0.60×
Volume ROC (10d)
-4.88%
Up/down volume
1.20×
OBV (20d)
Rising
Chaikin MF (20)
0.19
VWAP 20d
₹127.80 (-1.53%)
VWAP 50d
₹112.22 (+12.14%)
Anchored VWAP · 52W low
₹90.39 (+39.22%)
Anchored VWAP · 52W high
₹131.63 (-4.40%)
Anchored VWAP · YTD
₹86.25 (+45.90%)
Avg turnover (20d)
₹0.85 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal.

💪 Relative strength

vs Nifty 1M
-3.94%
vs Nifty 3M
+111.04%
vs Nifty 6M
+64.03%
vs Nifty 1Y
+56.73%
RS rating
97.00
Mansfield RS
67.13
vs Pharma index 3M
+105.03%
vs sector peers 3M
+107.55%

VALIANTLAB ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹141.38+12.3%1
Resistance₹130.00+3.3%3
Close₹125.84—
Support₹112.12−10.9%4
Support₹91.53−27.3%1
Support₹80.90−35.7%6
Support₹73.00−42.0%1

52-week range: ₹49.51 – ₹141.38 (-10.99% from the high).

🌀 Fibonacci

Measuring the up-swing from ₹58.08 (2026-07-31) to ₹141.38 (2026-10-19). Price has retraced 18.7% of it.

RatioPriceDistance
23.6% retracement₹121.72-3.3% nearest
38.2% retracement₹109.56-12.9%
50.0% retracement₹99.73-20.8%
61.8% retracement₹89.90-28.6%
78.6% retracement₹75.91-39.7%
127.2% extension₹164.04+30.4%
161.8% extension₹192.86+53.3%
200.0% extension₹224.68+78.5%

Next Fibonacci time zone: 89 sessions from the swing start ≈ 2026-12-08 (approximate — exchange holidays are not modelled).

🕯️ Candlesticks (last 5 sessions)

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
DIVISLABDivi's Laboratories Limited ₹9,945.50 +1.69% 94 Uptrend 92.00
ACUTAASAcutaas Chemicals Limited ₹3,892.60 -2.77% 87 Uptrend 96.00
SMSPHARMASMS Pharmaceuticals Limited ₹504.15 -1.41% 87 Strong Uptrend 92.00
CORONACORONA Remedies Limited ₹2,171.10 +1.00% 86 Uptrend 84.00
ZYDUSLIFEZydus Lifesciences Limited ₹1,240.50 -0.40% 85 Uptrend 85.00
PPLPHARMAPiramal Pharma Limited ₹239.92 +0.42% 83 Strong Uptrend 90.00
DRREDDYDr. Reddy's Laboratories Limited ₹1,342.00 -0.74% 82 Strong Uptrend 76.00
AARTIDRUGSAarti Drugs Limited ₹453.80 +4.27% 81 Strong Uptrend 77.00
ALIVUSAlivus Life Sciences Limited ₹1,447.60 +2.28% 81 Strong Uptrend 92.00
GLANDGland Pharma Limited ₹3,066.60 -0.95% 80 Uptrend 94.00
🔗 More on VALIANTLAB

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI